Schedule 13D ownership disclosure

GALECTO INC

Common Stock, par value $0.00001 per share · CUSIP: 36322Q107

Event date: 2025-10-07

Filing-level shares
0.00
Percent of class
0.0%
  • Novo Holdings A/SReported CIK 0001388325

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001388325-25-000007
Form type
SCHEDULE 13D/A
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Oct 09, 2025
Reporting period
Oct 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub